Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors

Carcinogenesis

Volumn 25, Issue 2, 2004, Pages 263-268

  Li, Junan ^a   Weghorst, Christopher M ^a,b   Tsutsumi, Masahiro ^c   Poi, Ming J ^a   Knobloch, Thomas J ^a   Casto, Bruce C ^a   Melvin, W Scott ^a,b   Tsai, Ming Daw ^a,b   Muscarella, Peter ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CYCLIN DEPENDENT KINASE 4; EOSIN; HEMATOXYLIN; PROTEIN P16; BIS(2 HYDROXYPROPYL)NITROSAMINE; NITROSAMINE; PROTEIN P16INK4A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE DELETION; GENE MUTATION; HAMSTER; HOMOZYGOSITY; MICROSCOPY; NONHUMAN; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; SEQUENCE ANALYSIS; STAINING; TUMOR CELL; TUMOR SUPPRESSOR GENE; ANIMAL; CHEMICALLY INDUCED DISORDER; HOMOZYGOTE; METABOLISM; MUTATION; SYRIAN HAMSTER;

ANIMALS; CPG ISLANDS; CRICETINAE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; GENE DELETION; HOMOZYGOTE; MESOCRICETUS; MUTATION; NITROSAMINES; PANCREATIC NEOPLASMS;

EID: 1342302487     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh007     Document Type: Article

References (37)

1. American Cancer Society (2003) Cancer Facts and Figures - 2003. New York, pp. 12-24.
2. Jemal,A., Murray,T., Samuels,A., Ghafoor,A., Ward,E. and Thun,M.J. (2003) Cancer statistics 2003. CA Cancer J. Clin., 53, 5-26.
3. National Cancer Institute (2001) Pancreatic Cancer: An Agenda for Action. Report of the Pancreatic Cancer Progress Review Group. NIH Publication Number 01-4940.
4. Caldas,C., Hahn,S.A., daCosta,L.T., Redston,M.S., Schutte,M., Seymour,A.B., Weinstein,C.L., Hruban,R.H., Yeo,C.J. and Kern,S.E. (1994) Frequent somatic mutations and homozygous deletions of the p16(MTS-1) gene in pancreatic adenocarcinoma. Nature Genet., 8, 27-32.
5. Liu,Q., Yan,Y-Z., McClure,M., Nakagawa,H., Fujumura,F. and Rustgi,A.K. (1995) MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagous squamous cancer and pancreatic cancer cell lines. Oncogene, 10, 619-622.
6. Huang,L., Goodrwo,T.L., Zhang,S.-Y., Klein-Szanto,A.J.P., Chang,H. and Ruggeri,B.A. (1996) Deletion and mutation analysis of the p16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Cancer Res., 56, 1137-1141.
7. Naumann,M., Savitskaia,N., Elert,C., Schramm,A., Kalthoff,H. and Schmiegel,W. (1996) Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology, 110, 1215-1224.
8. Schutte,M., Hruban,R.H., Geradts,J. et al. (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res., 57, 3126-3130.
9. Ortega,S., Malumbres,M. and Barbacid,M. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta, 1602, 73-87.
10. Li,J., Byeon,I.-J., Poi,M., Ericson,K., Selby,T., O'Maille,P., Qin,D. and Tsai,M.-D. (2000) The structure-function relationship of p16 tumor suppressor. In: Ehrlich,M. (ed.), DNA Alterations in Cancer: Genetic and Epigenetic Changes. BioTechniques Books, Eaton Publishing, MA, pp. 71-83.
11. INK4a expression adenovirus vector to suppress pancreatic cancer cell proliferation. Clin. Cancer Res., 5, 4185.
12. Pour,P.M., Runge,R.G., Birt,D., Gingell,R., Lawson,T., Nagel,D., Wallcave,L. and Salmasi,S.Z. (1981) Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer, 47, 1573-1587.
13. Erill,N., Cuatrecasas,M., Sancho,F.J., Farre,A., Pour,P.M., Lluis,F. and Capella,G. (1996) K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Am. J. Pathol., 149, 1333-1339.
14. VanKranen,H.J., Vermeulen,E., Schoren,L., Bax,J., Woutersen,R.A., VanIersel,P., Van Kreijl,C.F. and Scherer,E. (1991) Activation of c-Kras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis, 12, 1477-1482.
15. Chang,K.W., Laconi,S., Mangold,K.A., Hubchak,S. and Scarpelli,D.G. (1995) Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. Cancer Res., 55, 2560-2568.
16. Cerny,W.L., Mangold,K.A. and Scarpelli,D.G. (1992) K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res., 52, 4507-4513.
17. Chang,K.W., Mangold,K.A., Hubchak,S., Laconi,S. and Scarpelli,D.G. (1994) Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma. Cancer Res., 54, 3878-3883.
18. Li,J., Qin,D., Knobloch,T.J., Tsai,M.-D., Weghorst,C.M., Melvin,W.S. and Muscarella,P. (2003) Expression and characterization of Syrian Golden hamster p16, a homologue of human tumor suppressor p16INK4A. Biochem. Biophys. Res. Commun., 304, 241-247.
19. INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells. Gene, 278, 235-243.
20. Mizumoto,K., Tsutsumi,M., Denda,A. and Konishi,Y. (1988) Rapid production of pancreatic carcinoma by initiation with N-nitrosobis (2-oxopropyl) amine and repeated augmentation pressure in hamsters. J. Natl Cancer Inst., 80, 1564-1567.
21. Msoka,T. J., Nishioka,I., Taga,A., Kato,K., Kawasaki,H., Yamada,Y., Yu,A., Komada,Y. and Nobori,T. (2000) Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay. Leukemia, 14, 935-940.
22. Ruiz-Ponte,C., Loidi,L., Vega,A., Carracedo,A. and Barros,F. (2000) Rapid real-time fluorescent PCR gene dosage test for the diagnosis of DNA duplications and deletions. Clin. Chem., 46, 1574-1582.
23. INK4A. Biochemistry, 38, 2928-2940.
24. INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood, 97, 572-574.
25. INK4A gene alterations in hepatocellular carcinoma. Oncogene, 18, 789-795.
26. ARF in patients with severe oral epithelial dysplasia. Cancer Res., 62, 5295-5300.
27. Muscarella,P., Melvin,W.S., Fisher,W.E., Foor,J., Ellison,E.C., Herman,J.G., Schirmer,W.J., Hitchcock,C.L., DeYoung,B.R. and Weghorst,C.M. (1998) Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis pf p16/MTS1 tumor suppressor gene inactivation. Cancer Res., 58, 237-240.
28. Russo,A.A., Tong,L., Lee,J.O., Jeffrey,P.D. and Pavletich,N.P. (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature, 395, 237-243.
29. INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol. Cell, 1, 421-431.
30. Sugio,K., Gazdar,A.F., Albores-Saavedra,J. and Kokkinakis,D.M. (1996) High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso (2-hydroxypropyl) (2-oxopropyl)amine in the pancreas of female Syrian hamsters. Carcinogenesis, 17, 303-309.
31. Cerny,W.L., Mangold,K.A. and Scarpelli,D.G. (1990) Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Carcinogenesis, 11, 2075-2079.
32. Chang,K.-W., Mangold,K.A., Hubechak,S., Laconi,S. and Scarpelli,D.G. (1994) Genomic p53 mutations in a chemically induced hamster pancreatic ductal adenocarcinomas. Cancer Res., 54, 3878-3883.
33. Chang,K.-W., Laconi,S., Mangold,K.A., Hubchak,S. and Scarpelli,D.G. (1995) Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. Cancer Res., 55, 2560-2568.
34. Tsujiuchi,T., Sasaki,Y., Kubozoe,T., Konishi,Y. and Tsutsumi,M. (2003) Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis (2-oxopropyl)amine in hamsters. Mol. Carcinogen., 5, 4182-4185.
35. INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation. Clin. Cancer Res., 5, 4182-4185.
36. Ghaneh,G., Greenhalf,W., Humphreys,M., Wilson,D., Zumstein,L., Lemoine,N.R. and Neoptolemos,J.P. (2001) Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo. Gene Ther., 8, 199-208.
37. Jakubczak,J.L., Ryan,P., Gorziglia,M. et al. (2003) An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter and viral replication for selectivity and efficacy. Cancer Res., 63, 1490-1499.